190 related articles for article (PubMed ID: 7685994)
21. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
[TBL] [Abstract][Full Text] [Related]
22. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Hizi A; Shaharabany M; Tal R; Hughes SH
J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
[TBL] [Abstract][Full Text] [Related]
23. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Hizi A; Tal R; Shaharabany M; Loya S
J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide.
Buckheit RW; Kinjerski TL; Fliakas-Boltz V; Russell JD; Stup TL; Pallansch LA; Brouwer WG; Dao DC; Harrison WA; Schultz RJ
Antimicrob Agents Chemother; 1995 Dec; 39(12):2718-27. PubMed ID: 8593008
[TBL] [Abstract][Full Text] [Related]
25. Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Maass G; Immendoerfer U; Koenig B; Leser U; Mueller B; Goody R; Pfaff E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2612-7. PubMed ID: 7509144
[TBL] [Abstract][Full Text] [Related]
26. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
Sevilya Z; Loya S; Adir N; Hizi A
Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
[TBL] [Abstract][Full Text] [Related]
27. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
[TBL] [Abstract][Full Text] [Related]
29. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
Currens MJ; Mariner JM; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
[TBL] [Abstract][Full Text] [Related]
30. Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase.
Perach M; Rubinek T; Hizi A
J Virol; 1995 Jan; 69(1):509-12. PubMed ID: 7527086
[TBL] [Abstract][Full Text] [Related]
31. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
Xu ZQ; Buckheit RW; Stup TL; Flavin MT; Khilevich A; Rizzo JD; Lin L; Zembower DE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2179-84. PubMed ID: 9873509
[TBL] [Abstract][Full Text] [Related]
32. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
34. The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.
Auwerx J; Rodríguez-Barrios F; Ceccherini-Silberstein F; San-Félix A; Velázquez S; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
Mol Pharmacol; 2005 Sep; 68(3):652-9. PubMed ID: 15961674
[TBL] [Abstract][Full Text] [Related]
35. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
Amacker M; Hübscher U
J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940
[TBL] [Abstract][Full Text] [Related]
36. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
[TBL] [Abstract][Full Text] [Related]
37. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP
J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800
[TBL] [Abstract][Full Text] [Related]
38. Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs.
Kissel JD; Held DM; Hardy RW; Burke DH
AIDS Res Hum Retroviruses; 2007 May; 23(5):699-708. PubMed ID: 17530996
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.
Byrnes VW; Sardana VV; Schleif WA; Condra JH; Waterbury JA; Wolfgang JA; Long WJ; Schneider CL; Schlabach AJ; Wolanski BS
Antimicrob Agents Chemother; 1993 Aug; 37(8):1576-9. PubMed ID: 7692811
[TBL] [Abstract][Full Text] [Related]
40. Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs.
Bacolla A; Shih CK; Rose JM; Piras G; Warren TC; Grygon CA; Ingraham RH; Cousins RC; Greenwood DJ; Richman D
J Biol Chem; 1993 Aug; 268(22):16571-7. PubMed ID: 7688367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
